2026年8月4日 7:00 ET 发布 · 更新于 3 个月前 · 2 个来源
Eli Lilly Ripe for Stock Split After Obesity Drug-Fueled Rally
bloomberg
·
原始报道
Wall Street’s appetite for weight-loss drug stocks over the past four years has powered Eli Lilly & Co. to consistently trade above $1,000 per share. Now, some see the pharma giant’s stock as primed for a split.
原文